FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

QS, MDR Violations at Future Diagnostics

FDA warns Gelderland, Netherlands-based Future Diagnostics Solutions about Quality System and Medical Device Reporting violations in its manufacturing...

latest-news-card-1
Human Drugs

FTC Expands Junk Patent Challenges

The Federal Trade Commission says it is expanding its challenges to junk drug patents with warnings to 10 companies about over 300 patent listings for...

latest-news-card-1
Human Drugs

Thiopurine Alert on Intrahepatic Cholestasis of Pregnancy

FDA issues a safety alert on the rare risk of intrahepatic cholestasis of pregnancy associated with the use of thiopurines (azathioprine, 6-mercaptopu...

Human Drugs

OND 55 Drug Approvals in 2023

The CDER Office of New Drugs says it participated in 55 novel drug approvals in 2023.

latest-news-card-1
Biologics

Pfizer Gets Traditional Approval for Tivdak

FDA gives Pfizer traditional approval for its previously accelerated-approved Tivdak (tisotumab vedotin-tftv) for recurrent or metastatic cervical can...

latest-news-card-1
Medical Devices

SonarMed Recalls Airway Sensors

SonarMed recalls its SonarMed Airway acoustic ventilator sensors due to a restricted inner diameter of the device resulting in difficulty passing a su...

latest-news-card-1
Federal Register

Panel to Review Novo Nordisks Insulin Icodec

Federal Register notice: FDA schedules a 5/24 Advisory Committee meeting to discuss Novo Nordisks BLA for insulin icodec.

latest-news-card-1
Biologics

Human Allogeneic Cell Safety Testing Guide

FDA posts a draft guidance entitled Safety Testing of Human Allogeneic Cells Expanded for Use in Cell-Based Medical Products.

latest-news-card-1
Human Drugs

X4 Pharma Gains Xolremdi Approval

FDA approves an X4 Pharmaceuticals NDA for Xolremdi (mavorixafor) and its use in patients 12 years of age and older with WHIM syndrome (warts, hypogam...

latest-news-card-1
Federal Register

Guide on Composition and Ingredient Statements

Federal Register notice: FDA makes available a draft guidance entitled Content and Format of Composition Statements in NDAs and ANDAs and Correspondin...